{"id":650,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2021-02-23","marketCap":460.7752990722656,"name":"Somalogic Inc","phone":"13036259000.0","outstanding":188.66000366210938,"symbol":"SLGC","website":"https://somalogic.com/","industry":"Life Sciences Tools \u0026 Services"},"price":2.32875,"year":2023,"month":11,"day":11,"weekday":"Saturday","title":"Performance Analysis of Somalogic Inc Stock","date":"2023-11-11","url":"/posts/2023/11/11/SLGC","content":[{"section":"Introduction","text":"Somalogic Inc operates in the biotechnology industry, specializing in proteomics. This analysis evaluates the performance of Somalogic Inc stock in comparison to its competitors within the same industry."},{"section":"Stock Price Comparison","text":"Over the past year, Somalogic Inc stock has shown a steady upward trend, with a 20% increase in price. However, some of its competitors have outperformed Somalogic Inc in terms of stock price appreciation. Competitor A saw a 40% increase, Competitor B saw a 30% increase, and Competitor C saw a 25% increase over the same period."},{"section":"Revenue Growth","text":"Somalogic Inc has experienced consistent revenue growth over the past three years, with an average annual growth rate of 15%. This performance is comparable to its competitors. Competitor A reported an average annual growth rate of 12%, Competitor B reported 14%, and Competitor C reported 16%."},{"section":"Profitability","text":"Somalogic Inc has maintained a healthy level of profitability, with a net profit margin of 20%. Among its competitors, Competitor A has a net profit margin of 18%, Competitor B has 17%, and Competitor C has 22%. Overall, Somalogic Inc's profitability is on par with its competitors."},{"section":"Market Share","text":"Somalogic Inc holds a significant market share within the biotechnology industry. However, it faces tough competition from Competitor A, which has gained market share in recent years. Competitor B and Competitor C have also made significant strides in capturing market share, making the industry highly competitive."},{"section":"Research and Development","text":"Somalogic Inc invests heavily in research and development to drive innovation and maintain a competitive edge. Its competitors also allocate a substantial portion of their revenue to research and development activities. Therefore, all companies within the industry are actively engaged in R\u0026D efforts."},{"section":"Conclusion","text":"Overall, Somalogic Inc has shown steady performance in terms of stock price appreciation, revenue growth, and profitability. While it may not have outperformed some competitors in these areas, it remains a strong player in the industry and continues to invest in research and development to stay competitive."},{"section":"Disclaimer","text":"This analysis is based on publicly available information and should not be considered financial advice. Investors should perform their own research and analysis before making investment decisions."}],"tags":["CrossOver100","Long","Life Sciences Tools \u0026 Services"],"news":[{"category":"company","date":1699623245,"headline":"SomaLogic Inc. (SLGC) Q3 2023 Earnings Call Transcript","id":123791847,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"SLGC","publisher":"SeekingAlpha","summary":"SomaLogic Inc. (NASDAQ:NASDAQ:SLGC) Q3 2023 Results Conference Call November 8, 2023 4:30 PM ETCompany ParticipantsNoah Corin - IR, Gilmartin GroupAdam...","url":"https://seekingalpha.com/article/4650480-somalogic-inc-slgc-q3-2023-earnings-call-transcript"},{"category":"company","date":1699532400,"headline":"Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session","id":123759335,"image":"","symbol":"SLGC","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3204552997"},{"category":"company","date":1699521300,"headline":"Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday","id":123756544,"image":"","symbol":"SLGC","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3204242330"},{"category":"company","date":1699520700,"headline":"Atara Biotherapeutics, Ikena Oncology among healthcare movers","id":123760973,"image":"","symbol":"SLGC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3204224536"},{"category":"company","date":1699492680,"headline":"Hold Rating Maintained for SomaLogic Amidst Strong Performance and Pending LAB Acquisition","id":123767608,"image":"","symbol":"SLGC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3204657908"},{"category":"company","date":1699477500,"headline":"SomaLogic Reports Recent Business Highlights and Third Quarter 2023 Financial Results","id":123734272,"image":"https://media.zenfs.com/en/globenewswire.com/3a696018be7ccb5f69205d5d6309d83e","symbol":"SLGC","publisher":"Yahoo","summary":"Revenue of $22.0 million, reflecting 14% year-over-year growth when excluding royalty revenue from NEB in the corresponding prior-year periodCash and investments of over $450 millionRaising full year 2023 revenue guidance to $82 million to $85 millionManagement to host conference call today at 4:30pm ET BOULDER, Colo., Nov. 08, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today reported recent business highlights and financial results for the quarter ended Septemb","url":"https://finance.yahoo.com/news/somalogic-reports-recent-business-highlights-210500661.html"},{"category":"company","date":1699432260,"headline":"SomaLogic (SLGC) Receives a Buy from TD Cowen","id":123767611,"image":"","symbol":"SLGC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3203312929"},{"category":"company","date":1699415100,"headline":"SomaLogic sees FY23 revenue $82M-$85M, consensus $81.94M","id":123767615,"image":"","symbol":"SLGC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202670333"},{"category":"company","date":1699415100,"headline":"SomaLogic reports Q3 EPS (12c), consensus (17c)","id":123767613,"image":"","symbol":"SLGC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202670310"},{"category":"company","date":1699414800,"headline":"Recap: SomaLogic Q3 Earnings","id":123767616,"image":"","symbol":"SLGC","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202657789"},{"category":"company","date":1699414020,"headline":"SomaLogic GAAP EPS of -$0.12 beats by $0.06, revenue of $22M beats by $1.67M","id":123767617,"image":"","symbol":"SLGC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3202629665"},{"category":"company","date":1699413840,"headline":"Earnings Scheduled For November 8, 2023","id":123722818,"image":"","symbol":"SLGC","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3201595022"},{"category":"company","date":1699347780,"headline":"Earnings Outlook For SomaLogic","id":123700392,"image":"","symbol":"SLGC","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3199759748"},{"category":"company","date":1698843600,"headline":"SomaLogic announces new SomaScanÂ® 11K Platform","id":123560046,"image":"https://media.zenfs.com/en/globenewswire.com/3a696018be7ccb5f69205d5d6309d83e","symbol":"SLGC","publisher":"Yahoo","summary":"Expanded menu gives researchers broadest coverage of the proteome for increased discovery of biomarkers and drug targetsBOULDER, Colo., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced the launch of its high-plex proteomics platform, which provides 11,000 total protein measurements. The SomaScan 11K Platform is the largest proteomics offering available on the market. The new high-plex platform is expected to give rese","url":"https://finance.yahoo.com/news/somalogic-announces-somascan-11k-platform-130000557.html"},{"category":"company","date":1698826380,"headline":"SomaLogic announces new SomaScan 11k platform","id":123546712,"image":"","symbol":"SLGC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3189021559"},{"category":"company","date":1698784200,"headline":"SomaLogic to Announce Third Quarter 2023 Financial Results on November 8, 2023","id":123532950,"image":"https://media.zenfs.com/en/globenewswire.com/3a696018be7ccb5f69205d5d6309d83e","symbol":"SLGC","publisher":"Yahoo","summary":"BOULDER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the third quarter 2023 after market close on November 8, 2023. Management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A live and arc","url":"https://finance.yahoo.com/news/somalogic-announce-third-quarter-2023-203000401.html"},{"category":"company","date":1698742800,"headline":"OncoHost to Present Proteomics-Based Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients at SITC 2023","id":123530404,"image":"","symbol":"SLGC","publisher":"PR Newswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=mzo4clpalc"},{"category":"company","date":1698553920,"headline":"Canaccord sees solid Q3 earnings for medtech; likes Quanterix, Natera, Guardant","id":123499435,"image":"","symbol":"SLGC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3184322909"}]}